Bayesian Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,078
| Closed | -$1.46M | – | 1014 |
|
|
2023
Q3 | $1.46M | Buy |
+12,078
| New | +$1.46M | 0.17% | 154 |
|
|
2022
Q4 | – | Sell |
-8,140
| Closed | -$900K | – | 1019 |
|
|
2022
Q3 | $900K | Buy |
+8,140
| New | +$900K | 0.18% | 149 |
|
|
2022
Q2 | – | Sell |
-12,887
| Closed | -$1.01M | – | 1061 |
|
|
2022
Q1 | $1.01M | Buy |
+12,887
| New | +$1.01M | 0.15% | 207 |
|
|
2021
Q2 | – | Sell |
-11,400
| Closed | -$850K | – | 630 |
|
|
2021
Q1 | $850K | Buy |
+11,400
| New | +$850K | 0.2% | 141 |
|
|
2019
Q3 | – | Sell |
-2,900
| Closed | -$441K | – | 673 |
|
|
2019
Q2 | $441K | Buy |
+2,900
| New | +$441K | 0.09% | 286 |
|
|
2018
Q3 | – | Sell |
-3,615
| Closed | -$478K | – | 781 |
|
|
2018
Q2 | $478K | Buy |
3,615
+634
| +21% | +$83.8K | 0.11% | 275 |
|
|
2018
Q1 | $221K | Buy |
+2,981
| New | +$221K | 0.06% | 473 |
|
|
2017
Q4 | – | Sell |
-18,200
| Closed | -$826K | – | 713 |
|
|
2017
Q3 | $826K | Buy |
18,200
+12,100
| +198% | +$549K | 0.2% | 165 |
|
|
2017
Q2 | $206K | Buy |
+6,100
| New | +$206K | 0.08% | 365 |
|